Evan Newell

Evan Newell, PhD, is a Professor at Fred Hutchinson Cancer Center in Seattle, holding joint appointments in the Vaccine and Infectious Disease Division, Herbold Computational Biology Program, and Public Health Sciences Division. He leads the Newell Lab, focusing on understanding T-cell antigen-specificity in cancer and infectious diseases using cutting-edge technologies like mass cytometry. His work integrates computational biology and molecular immunology to develop novel biomarkers and therapeutic strategies.

• Education: PhD in Physiology from University of Toronto (2006), BSc in Immunology from McGill University (2000)
• Affiliations: Member of Immunotherapy Integrated Research Center (IIRC), Pathogen-Associated Malignancies IRC (PAM IRC), and Translational Data Science IRC (TDS IRC)

His research explores how T-cell diversity influences clinical outcomes in diseases like cancer and viral infections. By applying high-dimensional single-cell analysis, his lab identifies relationships between T-cell characteristics and antigen-specificity to guide personalized treatments. Recent projects include developing Infinity Flow software for immune cell analysis and discovering biomarkers for Merkel cell carcinoma immunotherapy.

Advising: Evan mentors graduate students and postdoctoral fellows in immunology and computational biology. His lab members include Tony Chour, Emily Park, and Guoyue Xu (graduate students), alongside postdoctoral researchers like Amy Codd and Allie Donlan.

Lab: Located in Fred Hutch's Steam Plant facility, the Newell Lab collaborates broadly across disciplines to advance translational immunology and data-driven biomedical research.